American Society of Regional Anesthesia and Pain Medicine May 2015 - (Page 17)
Regional Analgesia for Patients With Acute Rib Fractures
T
horacic trauma is the second most common unintentional
traumatic injury causing death in the United States.
Inadequate pain control after thoracic trauma has been
associated with higher morbidity and mortality.1 Uncontrolled rib
fracture pain impairs respiratory mechanics, decreases clearance
of secretions, and is associated with an increased incidence of
pulmonary complications.2 The prevalence of rib fractures among
trauma admissions is 10-15%, while pulmonary complication
rates range from 16-60% and mortality from 3-13%.2 Pulmonary
complications from acute rib fractures include flail chest,
pulmonary contusion, pneumothorax, hemothorax, pneumonia,
and atelectasis.3 The rate of pulmonary complications rises with
the number of rib fractures: one to two fractures have a 16.4%
complication rate, three to five fractures have a 33.6% rate, and
six or more have a 52.7% rate.3 Patients 65 years and older are
especially vulnerable to complications and have significantly
higher mortality rates.4 Current pain management strategies
range from oral and intravenous medications to regional analgesic
procedures.
The least invasive and most widely available treatments for acute
rib fracture pain are oral and intravenous medications including
acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs),
cyclooxygenase COX-1 and COX-2 inhibitors, and opioids. A
recent trial by Bayouth et al 5 has demonstrated the benefits of
including intravenous NSAIDS in the treatment of acute pain from
rib fractures. Patients who receive NSAIDs have a decreased
overall length of hospital
stay and morphine
requirements without an
increased risk of bleeding
complications. 5 Lidocaine
patches have also been
studied in the treatment
of rib fracture pain, but
the results of these
studies do not consistently
demonstrate improvement. 6
Strategies for opioid
administration include
oral, intravenous bolus,
and patient-controlled
analgesia. Systemic side
effects from opioids are well known and include sedation,
hypoxemia, respiratory depression, and nausea and vomiting. 6,7
Jennifer Bunch, MD
Anesthesiology Resident, CA-3
Department of Anesthesiology,
University of Florida,
Gainesville, Florida
Melanie Donnelly, MD, MPH
Assistant Professor
Department of Anesthesiology,
University of Colorado,
Aurora, Colorado
Section Editor: Steven Orebaugh, MD
analysis of studies using epidurals in rib fracture patients and
point out that there has not been consistent proof of benefit in
terms of the outcomes of mortality, ICU and hospital length of
stay, and duration of mechanical ventilation. The authors also
note that there may be increased risks associated with TEA in
this group of patients, who are frequently mechanically ventilated
and sedated during placement.1 However, there have not been
large-scale prospective studies of these patients, and, therefore,
it is difficult to assess any
specific increased risks. The
authors also demonstrate an
increased risk of hypotension
associated with the use of
TEA.1
"While evidence for equivalent analgesia
or respiratory outcomes between TEA and
PVB is scarce, there are clear situations
in which a practitioner may prefer a PVB
catheter over TEA due to the lower risk
of hypotension and ability to directly
visualize placement with ultrasound."
Several investigators have compared the efficacy of optimized
pharmacologic therapy with systemic opioids to that of thoracic
epidural analgesia (TEA) and have concluded that TEA is superior
for pain control.1,3,4,8-10 However, there has been some criticism
of the evidence supporting the widespread use of epidurals in
rib fracture patients. Carrier and colleagues1 performed a meta-
In the wake of this metaanalysis, a large study
using a national trauma
database was carried out
by Gage and colleagues. 11
These authors demonstrated
lower mortality in patients
receiving TEA who have
three or more rib fractures
at 30, 90, and 365 days post injury after controlling for location
(trauma center versus a nondesignated trauma center). The
authors speculated that TEA may improve mortality by reducing
the need for opioid therapy, thereby avoiding opioid-related side
effects. They also hypothesized that there may be benefits from
reductions in sympathetic hyperactivity and stress response,
which can be triggered by poorly controlled pain. 11 Todd and
colleagues 2 have shown that TEA, as part of a multidisciplinary
intervention in patients > 45 years of age and with four or more
American Society of Regional Anesthesia and Pain Medicine
2015
17
3
Table of Contents for the Digital Edition of American Society of Regional Anesthesia and Pain Medicine May 2015
President’s Message
Editorial
Pharmacogenetics in Monitoring of Chronic Pain Patients: Are We There Yet?
Phrenic Nerve Injury and Interscalene Nerve Block: Have We Learned Anything From the Surgical Treatment of Over 150 Cases of Diaphragmatic Paralysis From Multiple Etiologies?
An Exercise in Negotiation: The Success of the Pain Medicine Fellowship Match
Regional Analgesia for Patients with Acute Rib Fractures
Application of Regional Anesthetic Techniques for Cancer Pain
American Society of Regional Anesthesia and Pain Medicine May 2015
http://www.brightcopy.net/allen/asra/18-04
http://www.brightcopy.net/allen/asra/18-3
http://www.brightcopy.net/allen/asra/18-2
http://www.brightcopy.net/allen/asra/18-1
http://www.brightcopy.net/allen/asra/17-4
http://www.brightcopy.net/allen/asra/17-3
http://www.brightcopy.net/allen/asra/17-2
http://www.brightcopy.net/allen/asra/17-1
http://www.brightcopy.net/allen/asra/16-4
http://www.brightcopy.net/allen/asra/16-3
http://www.brightcopy.net/allen/asra/16-2
http://www.brightcopy.net/allen/asra/16-1
http://www.brightcopy.net/allen/asra/15-4
http://www.brightcopy.net/allen/asra/15-3
https://www.nxtbook.com/allen/asra/15-2
https://www.nxtbook.com/allen/asra/15-1
https://www.nxtbookmedia.com